A total of 1鈥?37 individuals (male 850, female 487), aged 27 to 91 years with HbA1c test were included. Participates with HbA1c 猢?.0%or FPG猢?.1 mmol/L underwent oral glucose tolerance test (OGTT). Diabetes mellitus was diagnosed according to the criteria of WHO in 1999, FPG猢?.0 mmol/L and/or OGTT 2 h-postload plasm glucose (2 h-PG)猢?1.1 mmol/L. The sensitivity and specificity of HbA1c thresholds and FPG or combination test on screening of diabetes were analyzed.
A total of 842 subjects had HbA1c <6.0%, in which 32 had isolated FPG猢?.1 mmol/L, of 495 had HbA1c猢?.0%. Subjects with HbA1c猢?.0%had significant increased disorder indexes than those with HbA1c<6.0%. 527 subjects who had HbA1c猢?.0%or FPG猢?.1 mmol/L underwent OGTT. A total of 234 subjects were newly diagnosed diabetes, including 123 (123/234, 52.56%) with FPG猢?.0 mmol/L, and 111 subjects (111/234, 47.43%) with isolated 2 h-PG猢?1.1 mmol/L. Among 234 new diabetes, 91.88%(215 subjects) had HbA1c猢?.3%, and 77.40%(181 subjects) had HbA1c猢?.5%. HbA1c猢?.3%combined FPG 猢?.0 mmol/L increased the positive rate of newly diagnosed diabetes from 91.88%to 96.58%.
HbA1c is a practical and convenient tool for screening undiagnosed diabetes in routine health check-up of a large population. Combined use of HbA1c猢?.3%and/or FPG猢?.0 mmol/L is efficient for early detection of diabetes.